X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (324) 324
index medicus (220) 220
male (172) 172
animals (156) 156
female (129) 129
platelet aggregation - drug effects (115) 115
platelet aggregation inhibitors - pharmacology (113) 113
aspirin (101) 101
platelet aggregation inhibitors - therapeutic use (96) 96
anti-platelet (95) 95
anti-platelet agents (77) 77
middle aged (77) 77
pharmacology & pharmacy (77) 77
blood platelets - drug effects (73) 73
hematology (71) 71
rats (70) 70
thrombosis (69) 69
anti-platelet therapy (66) 66
aged (65) 65
clopidogrel (65) 65
adult (63) 63
anti-platelet aggregation (61) 61
chemistry, medicinal (56) 56
treatment outcome (49) 49
mice (48) 48
rabbits (48) 48
cardiac & cardiovascular systems (47) 47
peripheral vascular disease (46) 46
platelet aggregation inhibitors - adverse effects (46) 46
risk factors (45) 45
platelet aggregation inhibitors - administration & dosage (44) 44
aggregation (41) 41
platelets (41) 41
surgery (40) 40
analysis (37) 37
percutaneous coronary intervention (37) 37
anticoagulants (35) 35
dose-response relationship, drug (35) 35
prevention (35) 35
ticlopidine - analogs & derivatives (35) 35
anti-platelet agent (34) 34
care and treatment (34) 34
blood platelets (33) 33
platelet aggregation inhibitors - chemistry (33) 33
stroke (33) 33
therapy (33) 33
in vitro techniques (32) 32
anticoagulants - therapeutic use (30) 30
aspirin - therapeutic use (30) 30
inhibition (30) 30
anti-platelet drugs (29) 29
biochemistry & molecular biology (29) 29
blood platelets - metabolism (29) 29
medicine & public health (29) 29
platelet aggregation (29) 29
myocardial-infarction (28) 28
time factors (28) 28
anti-inflammatory agents, non-steroidal - pharmacology (27) 27
chemistry, organic (27) 27
structure-activity relationship (27) 27
drug therapy, combination (26) 26
cardiac patients (24) 24
fibrinolytic agents - pharmacology (23) 23
platelet aggregation inhibitors - chemical synthesis (23) 23
thrombin (23) 23
ticlopidine - therapeutic use (23) 23
risk (22) 22
warfarin (22) 22
cardiology (21) 21
cardiovascular (21) 21
chemistry, multidisciplinary (21) 21
coronary heart disease (21) 21
health aspects (21) 21
aspirin - pharmacology (20) 20
bleeding (20) 20
collagen (20) 20
retrospective studies (20) 20
thrombosis - prevention & control (20) 20
acute coronary syndrome (19) 19
aspirin - administration & dosage (19) 19
atherosclerosis (19) 19
cardiovascular disease (19) 19
derivatives (19) 19
inhibitors (19) 19
molecular structure (19) 19
plant extracts - pharmacology (19) 19
activation (18) 18
anticoagulants - adverse effects (18) 18
antiplatelet therapy (18) 18
aspirin - adverse effects (18) 18
drug therapy (18) 18
fibrinolytic agents - therapeutic use (18) 18
mortality (18) 18
platelet (18) 18
platelet-aggregation (18) 18
research (18) 18
stent (18) 18
ticlopidine (18) 18
acute coronary syndromes (17) 17
anti-platelet activity (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (497) 497
Japanese (84) 84
Chinese (45) 45
French (11) 11
Korean (6) 6
German (4) 4
Spanish (4) 4
Hungarian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Child's Nervous System, ISSN 0256-7040, 4/2017, Volume 33, Issue 4, pp. 685 - 690
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 12/2018, Volume 28, Issue 23-24, pp. 3731 - 3735
Nitric oxide (NO) dysfunction has been found to be an important factor in both the development and progression of diabetic complications due to its many roles... 
Hypoglycemic | Dipeptidyl peptidase IV | Antioxidant | Nitric oxide | Sitagliptin derivatives | Anti-platelet aggregation | OXIDATIVE STRESS | POTENT | CHEMISTRY, MEDICINAL | INVOLVEMENT | CHEMISTRY, ORGANIC | DISCOVERY | Diabetes Mellitus, Experimental - drug therapy | Nitric Oxide Donors - chemistry | Sitagliptin Phosphate - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Platelet Aggregation Inhibitors - chemical synthesis | Platelet Aggregation Inhibitors - pharmacology | Nitric Oxide Donors - therapeutic use | Platelet Aggregation - drug effects | Nitric Oxide Donors - pharmacology | Diabetes Mellitus, Experimental - metabolism | Platelet Aggregation Inhibitors - therapeutic use | Hypoglycemic Agents - therapeutic use | Sitagliptin Phosphate - analogs & derivatives | Blood Glucose - analysis | Dipeptidyl-Peptidase IV Inhibitors - chemistry | Hypoglycemic Agents - chemistry | Mice, Inbred ICR | Hypoglycemic Agents - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - chemical synthesis | Animals | Sitagliptin Phosphate - chemical synthesis | Hypoglycemic Agents - chemical synthesis | Platelet Aggregation Inhibitors - chemistry | Sitagliptin Phosphate - therapeutic use | Molecular Docking Simulation | Nitric Oxide Donors - chemical synthesis | Oxidative Stress - drug effects | Blood Glucose - metabolism | Nitric Oxide - metabolism | Antioxidants | Hypoglycemic agents | Metabolites | Blood sugar | Endothelium
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 2019, Volume 119, Issue 3, pp. 461 - 466
The double-blind, randomized, AMPLIFY trial compared 6 months' treatment with apixaban (10 mg twice daily for 7 days and 5 mg twice daily thereafter) versus... 
Stroke, Systemic or Venous Thromboembolism | anti-platelet agents | deep vein thrombosis | PERIPHERAL VASCULAR DISEASE | APIXABAN | pulmonary embolism | HEMATOLOGY | venous thrombosis | clinical trials: oral anticoagulants
Journal Article
Journal Article
Pharmacological Research, ISSN 1043-6618, 07/2017, Volume 121, pp. 240 - 250
Stroke is a major cause of mortality and morbidity, particularly in the older ages. Women have a longer life expectancy and are more likely to experience... 
Systemic thrombolysis | Anti-platelet drugs | Gender differences | Anti-hypertensive drugs | Acute stroke | Risk stratification | TISSUE-PLASMINOGEN ACTIVATOR | VASCULAR EVENTS | SECONDARY PREVENTION | ACUTE STROKE CARE | CLINICAL PRESENTATION | CARDIOVASCULAR-DISEASE | BLOOD-PRESSURE CONTROL | PHARMACOLOGY & PHARMACY | INTRAARTERIAL THROMBOLYSIS | NONVALVULAR ATRIAL-FIBRILLATION | ORAL-CONTRACEPTIVES | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prognosis | Anticoagulants - administration & dosage | Humans | Stroke - diagnosis | Antihypertensive Agents - administration & dosage | Male | Fibrinolytic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Female | Stroke - epidemiology | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Risk Factors | Anticoagulants - therapeutic use | Stroke - drug therapy | Anticoagulants - adverse effects | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Brain Ischemia - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sex Factors | Brain Ischemia - diagnosis | Fibrinolytic Agents - administration & dosage | Quality of Health Care | Stroke (Disease) | Prevention | Hypertension | Heart | Enzyme inhibitors | Atrial fibrillation | Thrombin | Anticoagulants (Medicine) | Sex discrimination | Drug therapy | Risk factors | Cardiovascular agents
Journal Article
Journal of the Korean Association of Oral and Maxillofacial Surgeons, ISSN 2234-7550, 08/2018, Volume 44, Issue 4, pp. 143 - 150
The number of geriatric patients seeking dental service is ever-rising because of increased life expectancy, also with problem of increased chronic medical... 
Anti-thrombotic | Anti-coagulant | Minor oral surgery | Anti-platelet | Invited Review | 치의학
Journal Article
Therapeutic Apheresis and Dialysis, ISSN 1744-9979, 04/2019, Volume 23, Issue 2, pp. 133 - 144
Our previous small‐scale trial demonstrated an erythropoiesis stimulating agent (ESA)‐sparing potential of the TORAYLIGHT NV (NV) dialyzer in hemodialysis... 
Anti‐platelet activation membrane | Polysulfone membrane | NV dialyzer | Erythropoiesis stimulating agent resistance | Renal anemia | Anti-platelet activation membrane | C-REACTIVE PROTEIN | BIOCOMPATIBILITY | VITAMIN-E | RESPONSIVENESS | MULTICENTER | DIALYSIS-THERAPY | TRIAL | RESISTANCE | UROLOGY & NEPHROLOGY | JAPANESE-SOCIETY | ANEMIA | HEMATOLOGY | Hemodialysis | Analysis
Journal Article
Canadian Journal of Emergency Medicine, ISSN 1481-8035, 09/2018, Volume 20, Issue 5, pp. 774 - 776
Clinical question: Does the addition of topical tranexamic acid to anterior nasal packing decrease bleeding in patients with epistaxis who are taking... 
Tranexamic acid | Epistaxis | Anterior Nasal Packing | Anti-platelet | EMERGENCY MEDICINE | Studies | Validity | Anticoagulants | Medical research | Acids | Physicians | Otolaryngology | Clinical trials | Systematic review | Emergency medical care | Patient satisfaction | Patient assessment
Journal Article
Journal Article